why is compounded tirzepatide still being sold vs. Zepbound – Forbes Health Now that shortages of semaglutide

Unlike earlier-generation weight-management agents, retatrutide is a triple receptor agonist , meaning it simultaneously activates three distinct hormonal receptors: GLP-1 (glucagon-like peptide-1) receptor promotes insulin secretion, reduces appetite, and slows gastric emptying [9] [10] GIP (glucose-dependent insulinotropic polypeptide) receptor enhances insulin release and may improve fat metabolism [12] [13] Glucagon receptor increases energy expenditure and may reduce hepatic steatosis, as suggested by imaging data (MRI-PDFF) from Phase 2 trials, though this effect requires confirmation in larger studies [2] [5] This triple-agonist mechanism distinguishes retatrutide from agents such as semaglutide (GLP-1 only) or tirzepatide (GLP-1/GIP dual agonist), and is thought to produce more pronounced reductions in body weight and improvements in metabolic parameters

This innovative pen offers precision dosing, making it an ideal choice for diabetes management

Diet-derived antioxidants: the special case of ergothioneine

This method ensures your body receives 100% of the nutrients, compared to oral supplements, which can be less effective due to breakdown in the digestive process

For many individuals living with obesity or metabolic challenges, this reward system can become hypersensitive